Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Vivani Medical, Inc.
Report date June 24, 2025 · Filed June 26, 2025
Section 16 reporting ended · disclosed 2025-06-26. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.27 · Expires 2035-06-23 | Direct | 35,135 |
Reported balance
After 2025-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-24 · Grant · Acquired 35,135 · Balance 35,135 F2: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F1: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy.
F2: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2025 Filed Jun 26, 2025 19:27 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 35,135 | $1.27 Strike: $1.27 | $44,621.45 |
DisclosureSEC source: 0001753926-25-001029 · form4.xml · derivative · entry 1 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,135 Underlying: Common Stock · 35,135 shares Expires 2035-06-23 F2 · price: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's Non-Employee Director Compensation Policy. F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · derivative.underlying_shares: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service through such date. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 16:51 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 34,839 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001753926-24-001195 · ownership.xml · derivative · entry 1 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,839 Underlying: Common Stock · 34,839 shares Expires 2034-06-26 F1 · derivative.exercise_date: Annual grant awarded pursuant to the Issuer's non-employee director compensation policy. F2 · derivative.exercise_date: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date. F2 · balance_after: The option vests in total on the earlier of (i) the first anniversary of the grant and (ii) the next annual meeting of stockholders, subject to continued service through such date. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 19:27 UTC | Vivani Medical, Inc. VANI · Entity 6636 | GrantCommon Stock Option · Derivative | 32,121 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001753926-23-000811 · form_4.xml · derivative · entry 1 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,121 Underlying: Common Stock · 32,121 shares Expires 2033-06-15 F2 · derivative.exercise_date: Options vest monthly over a one-year period F1 · balance_after: Awarded as compensation for serving on the Board of Directors. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 19:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001202 · ownership.xml · derivative · entry 4 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2030-11-09 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 19:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001202 · ownership.xml · derivative · entry 3 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2029-11-11 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 19:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001202 · ownership.xml · derivative · entry 2 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,187 Underlying: Common Stock · 30,187 shares Expires 2028-11-13 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Aug 31, 2022 19:43 UTC | Vivani Medical, Inc. VANI · Entity 6636 | OtherCommon Stock | 197,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001202 · ownership.xml · nonDerivative · entry 1 Baker Wilford Dean · CIK 0001377879 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,482 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.